EG
Elston George
Chief Financial Officer
OtherM
Insider track record
CFONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Elston George, Chief Financial Officer. Director active across 2 companies, notably EyePoint Pharmaceuticals, Inc.. Aggregated, 20 filings have been recorded. Activity tracked since 9 February 2022. The latest transaction was filed on 20 August 2026 (J). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Elston George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
5,000 shares0Common StockSEC:0001429932-26-000010:0
5,000 shares0Common StockSEC:0001429932-26-000010:1
64,953 shares0Common StockSEC:0001429932-26-000010:2
64,953 shares0Common StockSEC:0001429932-26-000010:3
3,627 shares@ US$12.93100.0% of flowCommon StockSEC:0001429932-26-000008:1
7,500 shares0Common StockSEC:0001429932-26-000008:0
5,000 shares0Common StockSEC:0001429932-26-000006:0
15,285 shares0Common StockSEC:0001429932-26-000004:0
19,667 shares0Common StockSEC:0001429932-26-000002:0
5,000 shares0Common StockSEC:0001429932-25-000007:0
20,000 shares0Common StockSEC:0001429932-25-000005:0
7,500 shares0Common StockSEC:0001562180-25-004193:0
2,202 shares@ US$5.68100.0% of flowCommon StockSEC:0001562180-25-004193:1
5,834 shares0Common StockSEC:0001562180-25-001135:0
15,000 shares0Common StockSEC:0001562180-25-000229:0
7,500 shares0Common StockSEC:0001562180-24-004462:0
4,967 shares0Common StockSEC:0001562180-24-001291:0
15,285 shares0Common StockSEC:0001562180-24-000397:0
5,833 shares0Common StockSEC:0001562180-23-001331:0
4,966 shares0Common StockSEC:0001562180-22-001416:0
About Elston George
Elston George is Chief Financial Officer at EyePoint Pharmaceuticals, Inc. and EyePoint, Inc. He has 16 filings in total. In the 16 sampled recent filings available, the most common transaction nature is option exercise, with buy and sell amounts of EUR 0, and the period runs from 2022-02-11 to 2026-05-27.